Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study

BackgroundOsteoporosis (OP) is a systemic skeletal disease characterized by compromised bone strength leading to an increased risk of fracture. There is an ongoing debate on whether non-alcoholic fatty liver disease (NAFLD) is an active contributor or an innocent bystander in the pathogenesis of OP....

Full description

Bibliographic Details
Main Authors: Yue Zhou, Yunzhi Ni, Zhihong Wang, Gerald J. Prud’homme, Qinghua Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1283739/full
_version_ 1797393424849043456
author Yue Zhou
Yunzhi Ni
Zhihong Wang
Gerald J. Prud’homme
Qinghua Wang
author_facet Yue Zhou
Yunzhi Ni
Zhihong Wang
Gerald J. Prud’homme
Qinghua Wang
author_sort Yue Zhou
collection DOAJ
description BackgroundOsteoporosis (OP) is a systemic skeletal disease characterized by compromised bone strength leading to an increased risk of fracture. There is an ongoing debate on whether non-alcoholic fatty liver disease (NAFLD) is an active contributor or an innocent bystander in the pathogenesis of OP. The aim of this study was to assess the causal association between NAFLD and OP.MethodsWe performed two‐sample Mendelian randomization (MR) analyses to investigate the causal association between genetically predicted NAFLD [i.e., imaging‐based liver fat content (LFC), chronically elevated serum alanine aminotransferase (cALT) and biopsy-confirmed NAFLD] and risk of OP. The inverse variant weighted method was performed as main analysis to obtain the causal estimates.ResultsImaging-based LFC and biopsy-confirmed NAFLD demonstrated a suggestive causal association with OP ([odds ratio (OR): 1.003, 95% CI: 1.001-1.004, P < 0.001; OR: 1.001, 95% CI: 1.000-1.002, P = 0.031]). The association between cALT and OP showed a similar direction, but was not statistically significant (OR: 1.001, 95% CI: 1.000-1.002, P = 0.079). Repeated analyses after exclusion of genes associated with confounding factors showed consistent results. Sensitivity analysis indicated low heterogeneity, high reliability and low pleiotropy of the causal estimates.ConclusionThe two‐sample MR analyses suggest a causal association between genetically predicted NAFLD and OP.
first_indexed 2024-03-09T00:03:21Z
format Article
id doaj.art-c4127a0cedb34e8c8e8c3abbbcd4f84a
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-09T00:03:21Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-c4127a0cedb34e8c8e8c3abbbcd4f84a2023-12-12T15:26:07ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-12-011410.3389/fendo.2023.12837391283739Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization studyYue Zhou0Yunzhi Ni1Zhihong Wang2Gerald J. Prud’homme3Qinghua Wang4Department of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical School, Fudan University, Shanghai, ChinaDepartment of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical School, Fudan University, Shanghai, ChinaDepartment of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical School, Fudan University, Shanghai, ChinaDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, CanadaDepartment of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical School, Fudan University, Shanghai, ChinaBackgroundOsteoporosis (OP) is a systemic skeletal disease characterized by compromised bone strength leading to an increased risk of fracture. There is an ongoing debate on whether non-alcoholic fatty liver disease (NAFLD) is an active contributor or an innocent bystander in the pathogenesis of OP. The aim of this study was to assess the causal association between NAFLD and OP.MethodsWe performed two‐sample Mendelian randomization (MR) analyses to investigate the causal association between genetically predicted NAFLD [i.e., imaging‐based liver fat content (LFC), chronically elevated serum alanine aminotransferase (cALT) and biopsy-confirmed NAFLD] and risk of OP. The inverse variant weighted method was performed as main analysis to obtain the causal estimates.ResultsImaging-based LFC and biopsy-confirmed NAFLD demonstrated a suggestive causal association with OP ([odds ratio (OR): 1.003, 95% CI: 1.001-1.004, P < 0.001; OR: 1.001, 95% CI: 1.000-1.002, P = 0.031]). The association between cALT and OP showed a similar direction, but was not statistically significant (OR: 1.001, 95% CI: 1.000-1.002, P = 0.079). Repeated analyses after exclusion of genes associated with confounding factors showed consistent results. Sensitivity analysis indicated low heterogeneity, high reliability and low pleiotropy of the causal estimates.ConclusionThe two‐sample MR analyses suggest a causal association between genetically predicted NAFLD and OP.https://www.frontiersin.org/articles/10.3389/fendo.2023.1283739/fullMendelian randomizationcausalitynon-alcoholic fatty liver diseaseliver fat contentosteoporosis
spellingShingle Yue Zhou
Yunzhi Ni
Zhihong Wang
Gerald J. Prud’homme
Qinghua Wang
Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study
Frontiers in Endocrinology
Mendelian randomization
causality
non-alcoholic fatty liver disease
liver fat content
osteoporosis
title Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study
title_full Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study
title_fullStr Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study
title_full_unstemmed Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study
title_short Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study
title_sort causal effects of non alcoholic fatty liver disease on osteoporosis a mendelian randomization study
topic Mendelian randomization
causality
non-alcoholic fatty liver disease
liver fat content
osteoporosis
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1283739/full
work_keys_str_mv AT yuezhou causaleffectsofnonalcoholicfattyliverdiseaseonosteoporosisamendelianrandomizationstudy
AT yunzhini causaleffectsofnonalcoholicfattyliverdiseaseonosteoporosisamendelianrandomizationstudy
AT zhihongwang causaleffectsofnonalcoholicfattyliverdiseaseonosteoporosisamendelianrandomizationstudy
AT geraldjprudhomme causaleffectsofnonalcoholicfattyliverdiseaseonosteoporosisamendelianrandomizationstudy
AT qinghuawang causaleffectsofnonalcoholicfattyliverdiseaseonosteoporosisamendelianrandomizationstudy